Nurilla, Baby Boy .
HRN: 27-24-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/19/2025
06/26/2025
IV
42mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes